Home » Topics » BioWorld Science

BioWorld Science
RSS

Insmed submits NDA for ALIS for nontuberculous mycobacterial lung disease

April 3, 2018

Shanghai Pharmaceuticals initiates phase Ia trial with B-001 in patients with NHL

April 3, 2018

GSK initiates phase II study of SARM GSK-2881078 in patients with COPD

April 3, 2018

NIAID initiates phase I study of HIV-1 vaccines

April 3, 2018

FN-1501 identified as a novel FLT-3 and CDK inhibitor for the treatment of AML

April 3, 2018

C4X licenses orexin-1 receptor antagonist C4X-3256 to Indivior

March 29, 2018

Redx suspends enrollment in phase I/IIa study of RXC-004

March 29, 2018

Zeria Pharmaceutical applies for approval of Z-213 in Japan

March 29, 2018

Takeda considers making offer for Shire

March 29, 2018

Janssen files for approval of apalutamide in Japan

March 29, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...